[Clinical application of HIV protease inhibitors].
Chiba
N
N
Pharmaceuticals and Biotechnology Laboratory, Japan Energy Co., Saitama, Japan.
Shintani
M
M
Ueno
T
T
Hayashi
H
H
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D054303:HIV Reverse Transcriptase / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019888:Nelfinavir / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D054303:HIV Reverse Transcriptase; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir